Results 31 to 40 of about 845,442 (284)

CRISPRi-mediated characterization of novel anti-tuberculosis targets: Mycobacterial peptidoglycan modifications promote beta-lactam resistance and intracellular survival

open access: yesFrontiers in Cellular and Infection Microbiology, 2023
The lack of effective therapeutics against emerging multi-drug resistant strains of Mycobacterium tuberculosis (Mtb) prompts the identification of novel anti-tuberculosis targets.
Cátia Silveiro   +10 more
doaj   +1 more source

β-Lactam Allergy and Cross-Reactivity: A Clinician’s Guide to Selecting an Alternative Antibiotic

open access: yesJournal of Asthma and Allergy, 2021
Cristiano Caruso,1 Rocco Luigi Valluzzi,2 Stefania Colantuono,1 Francesco Gaeta,1 Antonino Romano3,4 1Allergy Unit, Columbus Hospital, Fondazione Policlinico A.
Caruso C   +4 more
doaj  

Design, synthesis, and evaluation the anti-β-lactamase activity of new sulphathiazole-derived monobactam compounds [PDF]

open access: yesالمجلة العراقية للصيدلة, 2020
Objectives: β-Lactams are the most successful antibiotics for the management of infectious diseases. Unfortunately, the bacterial production of β-lactamase that hydrolyzes the β-lactam ring can inactivate these drugs.
Ahmed Mahmood   +2 more
doaj   +1 more source

In Vitro Selection of High-Level Beta-Lactam Resistance in Methicillin-Susceptible Staphylococcus aureus

open access: yesAntibiotics, 2021
Selective pressure of beta-lactams is thought to be responsible for mutation selection in methicillin-susceptible Staphylococcus aureus (MSSA). We used next-generation sequencing to compare the genomes of beta-lactamase-positive (SA0707) and -negative ...
Vladimir Gostev   +6 more
doaj   +1 more source

Identification of drivers of mycobacterial resistance to peptidoglycan synthesis inhibitors

open access: yesFrontiers in Microbiology, 2022
Beta-lactams have been excluded from tuberculosis therapy due to the intrinsic resistance of Mycobacterium tuberculosis (Mtb) to this antibiotic class, usually attributed to a potent beta-lactamase, BlaC, and to an unusually complex cell wall.
Francisco Olivença   +8 more
doaj   +1 more source

Occurrence of TEM and SHV among extended-spectrum-beta lactamase producers of some Enterobacteriaceae members

open access: yesZagazig Journal of Pharmaceutical Sciences, 2016
This study aimed for the molecular detection of TEM and SHV genes in Extended-Spectrum beta-lactamases (ESBLs) clinical isolates of Enterobacteriace (Eshericichia coli, Klebsiella pneumoniae and Proteus spp.).
Ashraf Kadry   +2 more
doaj   +1 more source

Electron Donor–Acceptor Complex Catalysis in Synthetic Chemistry

open access: yesAngewandte Chemie, EarlyView.
Electron donor–acceptor (EDA) complexes are moving beyond stoichiometric photoactivation toward catalytic platforms for radical generation. Productive EDA catalysis requires coordinated donor–acceptor association, charge‐transfer excitation, radical reactivity, and vcatalyst turnover.
Tristan von Münchow   +3 more
wiley   +2 more sources

Switching ATP‐Forming Phosphoryl‐Transfer Chemistry With a Restricted Set of Amino Acids

open access: yesAngewandte Chemie, EarlyView.
Constraints on amino acid composition relevant to prebiotic chemistry reshape enzyme chemistry by replacing the canonical mechanism within a conserved protein fold with a distinct ATP‐forming reaction, ADP disproportionation. Such constraints generate alternative catalytic solutions not observed in modern enzymes and point to chemically plausible early
Sota Yagi   +3 more
wiley   +2 more sources

Evaluation of Risk Factors for Carbapenem-Resistant Klebsiella Pneumoniae Bacteremia

open access: yesSouthern Clinics of Istanbul Eurasia, 2020
INTRODUCTION[|]In recent years, carbapenem-resistant Klebsiella pneumoniae infections have become an important health problem in our country and all over the world.
Pınar Kıran   +2 more
doaj   +1 more source

Molecular Glue Degraders of TEM β‐Lactamases by Periplasmic Protease DegP

open access: yesAngewandte Chemie, EarlyView.
Molecular glues are developed that target TEM‐family β‐lactamases to the bacterial protease DegP for degradation. β‐Lactamase inhibitor tazobactam is identified as accelerating TEM β‐lactamase degradation by DegP, which is further enhanced by linkerless incorporation of dipeptides enriched among DegP substrates.
Emilia K. Taylor   +8 more
wiley   +2 more sources

Home - About - Disclaimer - Privacy